RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
The U.S. FDA has accepted for review a supplemental Biologics Licence Application (sBLA) seeking the approval of Keytruda (pembrolizumab) in combination with Alimta (pemetrexed) and Paraplatin (carboplatin) for patients with metastatic or advanced non-squamous non-small cell lung cancer (NSCLC) without mutations in EGFR or ALK genes.